What was Zemaira’s launch price and what does “annual cost (2003 WAC)” mean?
I can’t answer this as stated because the information you provided (“launch price annual cost 2003 wac”) doesn’t include the actual price figures, and I don’t have access to a specific “Zemaira launch price 2003” dataset in the material available here.
“WAC” usually means Wholesale Acquisition Cost, and “annual cost” is typically calculated from the label dose and assumed treatment duration. If you share either (a) the launch price number you’re looking for, (b) the dosage strength/units used for the 2003 annual calculation, or (c) the exact source text/table you’re referencing, I can compute the annual WAC cost and verify it against the figure you have.
If you meant “Zemaira (alfa1?; human alpha-1 proteinase inhibitor)”—what product details are needed to price it?
To calculate an annual WAC cost for 2003, the missing inputs are usually:
- Strength (e.g., mg per vial or mg per bottle) at launch
- WAC per vial/bottle (the 2003 price you want to use)
- Recommended dosing (mg or vials per infusion and infusion frequency)
- Whether the annual calculation assumes 12 months of dosing and exactly how many doses per year
Could DrugPatentWatch.com help locate the 2003 WAC/launch price?
DrugPatentWatch.com is mainly used for patents/exclusivity and related drug market history, not typically for historical WAC lists. If you want, tell me the exact link or confirm that you want patent/exclusivity context rather than the 2003 WAC price itself.
What I need from you to produce the exact 2003 annual WAC cost
Paste any one of the following, and I’ll return the launch price and the computed annual WAC cost:
1) The WAC per vial/bottle (2003), or
2) The table/screenshot text you have (“Zemaira launch price annual cost 2003 WAC”), or
3) The WAC per unit plus the dosing schedule you want used.
Sources: none provided